Positive and negative roles of CD72 in B cell function

Regulation of B cell activation depends on integration of signals transmitted by the B cell receptor (BCR) and a variety of co-receptors. CD72 is a B cell co-receptor that is expressed in all stages of B cell development except plasma cells. Ligation of CD72 enhances B cell growth and differentiation. Recently, the class IV semaphoring, CD 100, has been identified as the natural ligand for CD72. Cytoplasmic domain of CD72 has been shown to be associated with SHP-1 leading to the proposal that the positive effects of CD72 on B cell response may result from sequestration of negative signals from BCR. However, association of CD72 with Grb2 and/or CD19 suggests that CD72 could transmit positive signals. Based on these data, we propose a dual signaling model of CD72.

[1]  A. Elhabazi,et al.  CD100 is a leukocyte semaphorin , 1998, Cellular and Molecular Life Sciences CMLS.

[2]  E. C. Snow,et al.  Enhancement by monoclonal anti-Lyb-2 antibody of antigen-specific B lymphocyte expansion stimulated by TNP-Ficoll and T lymphocyte-derived factors. , 1986, Journal of immunology.

[3]  M. Ogimoto,et al.  Regulation of lipopolysaccharide- and IL-4-induced immunoglobulin heavy chain gene activation: differential roles for CD45 and Lyb-2. , 1992, International Immunology.

[4]  M. Kamal,et al.  Stimulation of B lymphocytes via CD72 (human Lyb‐2) , 1991, European journal of immunology.

[5]  H. Van de Velde,et al.  Ly-1 (CD5), a membrane glycoprotein of mouse T lymphocytes and a subset of B cells, is a natural ligand of the B cell surface protein Lyb-2 (CD72). , 1992, Journal of immunology.

[6]  W. Paul,et al.  Differential induction of class II gene expression in murine pre-B-cell lines by B-cell stimulatory factor-1 and by antibodies to B-cell surface antigens. , 1988, The Journal of molecular and cellular immunology : JMCI.

[7]  M. Matsumoto,et al.  Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. , 2000, Immunity.

[8]  T Pawson,et al.  Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav , 1994, Molecular and cellular biology.

[9]  J. Kinet,et al.  The Emerging Field of Receptor-Mediated Inhibitory Signaling: SHP or SHIP? , 1996, Cell.

[10]  I. von Hoegen,et al.  Sequence of the Lyb-2 B-cell differentiation antigen defines a gene superfamily of receptors with inverted membrane orientation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[11]  H. Velde,et al.  The B-cell surface protein CD72/Lyb-2 is the ligand for CDS , 1991, Nature.

[12]  C. Goodnow,et al.  Regulation of mouse CD72 gene expression during B lymphocyte development. , 1998, Journal of immunology.

[13]  D. E. Myers,et al.  An anti-CD72 immunotoxin against therapy-refractory B-lineage acute lymphoblastic leukemia. , 1995, Leukemia & lymphoma.

[14]  C. Leprince,et al.  B cell antigen receptor-mediated apoptosis. Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking. , 1995, Journal of immunology.

[15]  CD22 cross-linking generates B-cell antigen receptor-independent signals that activate the JNK/SAPK signaling cascade. , 1999 .

[16]  N. Muthusamy,et al.  Activation of lyn, blk, and btk but not syk in CD72-stimulated B lymphocytes. , 1998, Journal of immunology.

[17]  A. Miller,et al.  CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. , 1996, Immunity.

[18]  J. Parnes,et al.  PU.1/Spi-1 is essential for the B cell-specific activity of the mouse CD72 promoter. , 1998, Journal of immunology.

[19]  S. Grupp,et al.  Early events in B-cell activation: anti-Lyb2, but not BSF-1, induces a phosphatidylinositol response in murine B cells. , 1987, Cellular immunology.

[20]  D. Mosier,et al.  Activation of B lymphocytes by monovalent anti-Lyb-2 antibodies , 1984, The Journal of experimental medicine.

[21]  D. Mosier,et al.  Lyb Antigens and their Role in B Lymphocyte Activation , 1983, Immunological reviews.

[22]  K. Rajewsky,et al.  In Vivo Ablation of Surface Immunoglobulin on Mature B Cells by Inducible Gene Targeting Results in Rapid Cell Death , 1997, Cell.

[23]  E. Boyse,et al.  Antigenic complexity and protein-structural polymorphism in the Lyb-2 system , 2004, Immunogenetics.

[24]  S. Bondada,et al.  Negative regulation of antigen receptor‐mediated signaling by constitutive asociation of CD5 with the SHP‐1 protein tyrosine phosphatase in B‐1 B cells , 1999, European journal of immunology.

[25]  H. Yakura,et al.  Lyb-2 system of mouse B cells. Evidence for a role in the generation of antibody-forming cells , 1981, The Journal of experimental medicine.

[26]  T. Kurosaki,et al.  Requirement of SH2-containing Protein Tyrosine Phosphatases SHP-1 and SHP-2 for Paired Immunoglobulin-like Receptor B (PIR-B)–mediated Inhibitory Signal , 1998, The Journal of experimental medicine.

[27]  Wei Wei Wu,et al.  Transgene Expression of bcl-xL Permits Anti-immunoglobulin (Ig)–induced Proliferation in xid B Cells , 1998, The Journal of experimental medicine.

[28]  Occupancy of CD72 (the CD5 counterstructure) enhances interleukin-4-dependent CD23 expression in resting B lymphocytes. , 1992, Immunology.

[29]  N. Solvason,et al.  Murine CD38: an immunoregulatory ectoenzyme. , 1995, Immunology today.

[30]  I. Stamenkovic,et al.  Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes , 1996, The Journal of experimental medicine.

[31]  M. Reth,et al.  The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation. , 1998, Journal of immunology.

[32]  M. Ikawa,et al.  The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice. , 2000, Immunity.

[33]  Ching-shih Chen,et al.  CD72‐mediated B cell activation involves recruitment of CD19 and activation of phosphatidylinositol 3‐kinase , 1998, European journal of immunology.

[34]  W. Robinson,et al.  Extensive polymorphism in the extracellular domain of the mouse B cell differentiation antigen Lyb-2/CD72. , 1992, Journal of immunology.

[35]  D. Mosier,et al.  Induction of B lymphocyte proliferation by monoclonal anti-Lyb 2 antibody. , 1983, Journal of immunology.

[36]  T. Adachi,et al.  CD72 Negatively Regulates Signaling Through the Antigen Receptor of B Cells1 , 2000, The Journal of Immunology.

[37]  J. Gordon,et al.  B-cell signalling via the C-type lectins CD23 and CD72. , 1994, Immunology today.

[38]  B. Dörken,et al.  Human Lyb‐2 homolog CD72 is a marker for progenitor B‐cell leukemias , 1992, American journal of hematology.

[39]  T. Pawson,et al.  The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1 , 1998, Current Biology.

[40]  M. Tongio,et al.  The dendritic cell lineage: a ubiquitous antigen-presenting organization. , 1996, The Annals of thoracic surgery.

[41]  B. Subbarao,et al.  Properties of anti-Lyb-2-mediated B-cell activation and the relationship between Lyb-2 molecules and receptors for B-cell stimulatory factor-1 on murine B lymphocytes. , 1988, Cellular immunology.

[42]  E. Krebs,et al.  The MAPK signaling cascade , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  Christopher C. Goodnow,et al.  How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis , 2000, Nature.

[44]  M. Neuberger,et al.  Hyperresponsive B Cells in CD22-Deficient Mice , 1996, Science.

[45]  Chen Dong,et al.  Positive Signaling Through CD72 Induces Mitogen-Activated Protein Kinase Activation and Synergizes with B Cell Receptor Signals to Induce X-Linked Immunodeficiency B Cell Proliferation1 , 2001, The Journal of Immunology.

[46]  T. Kurosaki,et al.  Deletion of SHIP or SHP-1 Reveals Two Distinct Pathways for Inhibitory Signaling , 1997, Cell.

[47]  S. Tomita,et al.  BLNK is associated with the CD72 / SHP‐1 / Grb2 complex in the WEHI231 cell line after membrane IgM cross‐linking , 2000, European journal of immunology.

[48]  R. Perlmutter,et al.  CD22 regulates thymus-independent responses and the lifespan of B cells , 1996, Nature.

[49]  M. Inaoki,et al.  The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. , 1997, Immunity.

[50]  M. Bowen,et al.  Interaction of recombinant and natural soluble CD5 forms with an alternative cell surface ligand , 1999, European journal of immunology.

[51]  A. Aruffo,et al.  A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5. , 1998, International immunology.

[52]  S. Bondada,et al.  CD5-Mediated Negative Regulation of Antigen Receptor-Induced Growth Signals in B-1 B Cells , 1996, Science.

[53]  N. Muthusamy,et al.  Differential regulation of surface Ig- and Lyb2-mediated B cell activation by cyclic AMP. I. Evidence for alternative regulation of signaling through two different receptors linked to phosphatidylinositol hydrolysis in murine B cells. , 1991, Journal of immunology.

[54]  D. Fearon,et al.  A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. , 1995, Science.

[55]  W. Robinson,et al.  Allele-specific expression of the mouse B-cell surface protein CD72 on T cells , 1997, Immunogenetics.

[56]  N. Baumgarth,et al.  CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation. , 1999, Immunity.

[57]  J. Banchereau,et al.  The CD40 antigen and its ligand. , 1994, Annual review of immunology.

[58]  W. Fridman,et al.  Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. , 1992, Science.

[59]  T. Nomura,et al.  Antigen receptor-mediated B cell death is blocked by signaling via CD72 or treatment with dextran sulfate and is defective in autoimmunity-prone mice. , 1996, International immunology.

[60]  M. Cooper,et al.  B cells in the bursa of Fabricius express a novel C-type lectin gene. , 1997, Journal of immunology.

[61]  K. Siminovitch,et al.  The Motheaten Mutation Rescues B Cell Signaling and Development in CD45-deficient Mice , 1997, The Journal of experimental medicine.

[62]  L. Justement.  Signal transduction via the B-cell antigen receptor: the role of protein tyrosine kinases and protein tyrosine phosphatases. , 2000, Current topics in microbiology and immunology.

[63]  G. Köhler,et al.  CD22 is a negative regulator of B-cell receptor signalling , 1997, Current Biology.

[64]  H. Yakura,et al.  Evidence that Lyb-2 is critical to specific activation of B cells before they become responsive to T cell and other signals , 1982, The Journal of experimental medicine.